Fig. 5From: In silico analysis of HLA-1 and HLA-2 recognition of a designed recombinant human papillomavirus vaccine based on L1 protein HPV subtype 45Distribution of HPV-related HLA-2 alleles, which contribute to the clearance/regression of the disease. (Light grey indicates the area where no data was available)Back to article page